Parallel Squared Technology Institute (PTI) is a non-profit research institute developing technologies, reagents, and computational tools to increase the sensitivity and throughput of protein analysis, with a specific focus on single-cell proteomics. We are applying these innovations to societally-relevant areas of biomedical research. As part of these efforts, we are developing new approaches to study protein dysfunctions in Alzheimer’s and related neurodegenerative diseases. Summary of Position We are seeking scientist and senior scientist candidates to help drive our efforts to use single-cell proteomics to understand the causes of Alzheimer’s and related neurodegenerative diseases. Ideal candidates will have expertise in the molecular mechanisms of neurodegeneration and direct, hand-on experience in single-cell analysis, computational biology, and brain tissue handling. Candidates will have the opportunity to work as part of an interdisciplinary team in multiple areas, including on NIH-funded projects, using proteomic technologies developed at PTI to discover new molecular mechanisms of neurodegeneration in Alzheimer’s and related disorders. Day-to-day responsibilities include designing and carrying out experiments to isolate and profile single cells from brain tissue, computationally analyzing large-scale single-cell proteomics datasets, preparing manuscripts and presentations, mentoring junior scientists, and regular meetings with collaborators in and outside of PTI. Candidates will initially work on ongoing projects but will have the opportunity to design and lead their own projects as well. Candidates with less than 1 year of postdoctoral experience will be considered for the scientist position and those with more than 1 year of experience will be considered for the senior scientist position. About PTI PTI is a nonprofit, focused research organization (FRO) established through Convergent Research. FROs aim to accelerate progress across science and technology by tackling large-scale problems with the potential to unlock existing bottlenecks in specific research areas. PTI aims to achieve a 100-1000x increase in the scale of proteomic analysis. To do so, we are developing new technologies and approaches for mass spectrometric proteomics. This includes molecular barcodes, termed “mass tags” that enable sample multiplexing, as well as computational approaches for increasing the sensitivity of protein analysis. We aim to apply these advances in societally-relevant areas, with a specific focus on neurodegenerative disease. To do so, we are collaborating with leaders in neurodegenerative disease from around the world. To learn more about PTI’s approach for studying neurodegenerative disease, please visit this page. To learn more about our technology for increasing the throughput of protein analysis, please visit here. Researchers at PTI have the opportunity to work within an interdisciplinary team of mass spectrometrists, chemists, computational analysts, and biologists to push the boundaries of protein analysis. PTI supports professional development through educational opportunities such as travel to conferences workshops. Members of PTI receive industry-level resources to lead research projects and have the opportunity to disseminate their discoveries and innovations through high-visibility publications, presentations, and submissions to public data portals.